Pilot Study of Metabolomic Clusters as State Markers of Major Depression and Outcomes to CBT Treatment-Reference-Cited by-同舟云学术

Pilot Study of Metabolomic Clusters as State Markers of Major Depression and Outcomes to CBT Treatment

Published:2019-09-12 Issue: Volume:13 Page:
ISSN:1662-453X
Container-title:Frontiers in Neuroscience
language:
Short-container-title:Front. Neurosci.

Author:

Bhattacharyya Sudeepa,Dunlop Boadie W.,Mahmoudiandehkordi Siamak,Ahmed Ahmed T.,Louie Gregory,Frye Mark A.,Weinshilboum Richard M.,Krishnan Ranga R.,Rush A. John,Mayberg Helen S.,Craighead W. Edward,Kaddurah-Daouk Rima

Funder

National Institutes of Health

Emory University

Publisher

Frontiers Media SA

Subject

General Neuroscience

Reference38 articles.

1. Merging pharmacometabolomics with pharmacogenomics using “1000 Genomes” single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics.;Abo;Pharmacogenet Genomics,2012

2. Branched-chain amino acids as new biomarkers of major depression - a novel neurobiology of mood disorder.;Baranyi;PLoS One,2016

3. Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients.;Bhattacharyya;Transl. Psychiatry,2019

4. Effect of Allium macrostemon on a rat model of depression studied by using plasma lipid and acylcarnitine profiles from liquid chromatography/mass spectrometry.;Chen;J. Pharm. Biomed. Anal.,2014

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acylcarnitines are associated with lower depressive symptomatology in a mainland puerto rican cohort;Metabolomics;2024-07-27

2. Metabolomics Signatures of serotonin reuptake inhibitor (Escitalopram), serotonin norepinephrine reuptake inhibitor (Duloxetine) and Cognitive Behavior Therapy on Key Neurotransmitter Pathways in Major Depressive Disorder;2024-04-03

3. Microbiota in psychiatry;Microbiota Brain Axis;2024

4. A computational account of joint SSRI and anti-inflammatory treatment;2023-12-27

5. Astragalus polysaccharide ameliorated complex factor-induced chronic fatigue syndrome by modulating the gut microbiota and metabolites in mice;Biomedicine & Pharmacotherapy;2023-07